Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 25 | $37,310,897 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
17 Apr 2024 17:19 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 15 Apr 2024 | Sale | 12,587 | 133.3646 | 1,678,660 | D |
17 Apr 2024 17:19 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 15 Apr 2024 | Sale | 7,231 | 133.3646 | 964,359 | D |
15 Mar 2024 17:33 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 14 Mar 2024 | Sale | 69,521 | 139.3789 | 9,689,761 | D |
15 Mar 2024 17:33 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 14 Mar 2024 | Sale | 5,479 | 139.3789 | 763,657 | D |
29 Feb 2024 18:55 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 28 Feb 2024 | Sale | 21,857 | 134.6881 | 2,943,878 | D |
29 Feb 2024 18:55 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 28 Feb 2024 | Sale | 53,143 | 134.6881 | 7,157,730 | D |
15 Feb 2024 17:29 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 13 Feb 2024 | Sale | 1,098 | 133.0149 | 146,050 | D |
08 Feb 2024 19:15 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 08 Feb 2024 | Sale | 980 | 134.1925 | 131,509 | D |
08 Feb 2024 19:15 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 06 Feb 2024 | Sale | 1,280 | 142.1172 | 181,910 | D |
02 Feb 2024 19:05 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 31 Jan 2024 | Sale | 1,207 | 140.7844 | 169,927 | D |
23 Aug 2023 19:59 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 21 Aug 2023 | Sale | 1,600 | 107.3975 | 171,836 | D |
08 Feb 2023 19:18 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 08 Feb 2023 | Sale | 980 | 104.1184 | 102,036 | D |
08 Feb 2023 19:18 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 07 Feb 2023 | Sale | 15,360 | 102.4235 | 1,573,225 | D |
08 Feb 2023 19:18 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 07 Feb 2023 | Sale | 2,030 | 102.2872 | 207,643 | D |
08 Feb 2023 19:18 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 06 Feb 2023 | Sale | 1,280 | 105.6256 | 135,201 | D |
02 Feb 2023 17:00 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 31 Jan 2023 | Sale | 1,207 | 109.9505 | 132,710 | D |
10 Jan 2023 17:13 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 06 Jan 2023 | Sale | 400 | 125 | 50,000 | D |
01 Dec 2022 18:43 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 30 Nov 2022 | Sale | 20,063 | 125.9017 | 2,525,966 | D |
01 Dec 2022 18:43 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 30 Nov 2022 | Sale | 7,775 | 125.9017 | 978,886 | D |
01 Dec 2022 18:43 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 30 Nov 2022 | Sale | 22,162 | 125.9017 | 2,790,233 | D |
10 Nov 2022 17:50 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 10 Nov 2022 | Sale | 100 | 125.362 | 12,536 | D |
10 Nov 2022 17:50 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 08 Nov 2022 | Sale | 24,593 | 125.3332 | 3,082,319 | D |
04 Nov 2022 16:56 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 03 Nov 2022 | Sale | 8,968 | 125.0204 | 1,121,183 | D |
04 Nov 2022 16:56 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 02 Nov 2022 | Sale | 400 | 125 | 50,000 | D |
19 Oct 2022 17:55 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 17 Oct 2022 | Sale | 4,960 | 110.8229 | 549,682 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)